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HHV-8 ORF K1Human herpesvirus-8 (HHV-8) variants have been found heterogeneously distributed among human
populations living in diverse geographic regions, but their differential pathogenicity in Kaposi's sarcoma
development remains controversial. In the present study, HHV-8 variant distribution has been analyzed in
classic, iatrogenic, endemic as well as epidemic Kaposi's sarcoma (KS) during pre-AIDS and AIDS period
(1971–2008) in countries with different KS incidence rate. DNA samples from cutaneous KS lesions of 68
patients living in Africa (n=23, Cameroon, Kenya and Uganda), Europe (n=34, Greece and Italy) and North
America (n=11) have been subjected to PCR ampliﬁcation of HHV-8 ORF 26, T0.7, K1 and K14.1/15,
followed by direct nucleotide sequencing and phylogenetic analysis. Among the 23 African samples, the
majority of HHV-8 ORF 26 variants clustered with the subtype R (n=12) and B (n=5). Conversely, the viral
sequences obtained from 45 European and North European tumors belonged mainly to subtype A/C
(n=36). In general, HHV-8 and K1 variant clustering paralleled that of ORF 26 and T0.7. Genotyping of the
K14.1/15 loci revealed a large predominance of P subtype in all tumors. In conclusion, comparison of the
HHV-8 sequences from classic or endemic versus AIDS-associated KS showed a strong linkage of the HHV-8
variants with speciﬁc populations, which has not changed during AIDS epidemic.
© 2009 Elsevier Inc. All rights reserved.Introduction
Kaposi sarcoma (KS), a mesenchymal tumor involving blood and
lymphatic vessels (Safai and Good, 1981;Pyakurel et al., 2006), is
characterized by four different clinical and epidemiological settings
(Schwartz et al., 2008): (1) classic KS, mainly occurring in elderly men
of Mediterranean or Eastern European Ashkenazi origin, with speciﬁc
geographic foci in Italy, Greece, Turkey and Israel (Iscovich et al.,
2000;Guttman-Yassky et al., 2003;Dal Maso et al., 2005;Buonaguro et
al., 2003); (2) African-endemic KS which existed for many decades
before human immunodeﬁciency virus (HIV) infection in some
equatorial African countries (Buonaguro et al., 2003;Serwadda et al.,
1986;Oettlé, 1962;Templeton, 1981); (3) iatrogenic KS, developing in
solid organ transplantation recipients following immunosuppressive
drug treatment (Buonaguro et al., 2003;Stribling et al., 1978;Penn,in.it (F.M. Buonaguro).
ll rights reserved.1983;Tessari et al., 2006); and (4) epidemic or AIDS-associated KS,
which has been the most frequent neoplasm in homosexual and
bisexualmenwith AIDS before the HAART era (Buonaguro et al., 2003;
Biggar et al., 1987;Dal Maso et al., 2009;Beral et al., 1990).
Herpes-type viruses have been suggested to play a role in KS for
more than 20 years (Giraldo et al., 1972;Giraldo et al., 1980), but only
in the late 1994 speciﬁc DNA sequences of a new KS-associated virus,
the human herpesvirus type 8 (HHV-8), were identiﬁed in AIDS-
associated KS (Chang et al., 1994). This virus is now considered as the
etiological agent of all clinic-epidemiological forms of this tumor type
(Buonaguro et al., 1996;Moore and Chang, 2003;Buonaguro et al.,
2003). Phylogenetic studies performed on the well-conserved ORF 26
(minor capsid gene) allowed the identiﬁcation of eight distinctive
subtypes designated as A/C, J, K/M, D/E, B, Q, R or N groups, which are
diversely distributed in different geographical regions. In particular,
four subtypes (B, N, Q and R) have been found virtually exclusively
among Sub-Saharan African samples, one (D/E) has been found only
within indigenous South Asian and Polynesian (Paciﬁc Rim) popula-
tions and three (A/C, J and K) have been identiﬁed almost exclusively
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Eastern) (Zong et al., 2007). Sequence analysis of the highly variable
ORF K1 region has allowed the identiﬁcation of seven major HHV-
8 subtypes (A, B, C, D, E, F and Z), comprising each several sub-clades,
whose distribution in the world parallels that of ORF 26 variants:
HHV-8 subtype B predominates in Africa and F has been identiﬁed in
Ugandan Bantu tribe, subtype D is present in the Paciﬁc islands;
subtype E clusters in ancient populations, like Brazilian Amerindians,
while A and C predominate in Europe and USA (Zong et al., 1999;Poole
et al., 1999;Biggar et al., 2000;Kasolo et al., 1998;Kajumbula et al.,
2006). It is still unclear whether different genotypes may have
different pathogenic and tumorigenic properties associated with
diverse rates of disease progression (Mancuso et al., 2008;Whitby
et al., 2004).
Seroepidemiological surveys indicated that HHV-8 is not a
ubiquitous virus, in contrast to the only other human γ-herpesvirus
Epstein–Barr virus, but its presence is mainly restricted to areas of
high endemicity for classic or endemic KS (Boshoff and Weiss, 2001;
Dedicoat and Newton, 2003). However, it is noteworthy that the
incidence of KS has changed markedly during AIDS epidemic
particularly across the African continent: before the HIV epidemic
KS was a disease primarily affecting men, with extreme incidence
variation among speciﬁc populations in different geographical
regions. In Uganda from 1954 to 1960 and 1968 to 1970, KS
represented 6.4% to 6.6% of all male cancer patients, respectively,
with rare female cases (Davies et al., 1965;Templeton et al., 1972).
However, in 1989 to 1991 period, KS prevalence in male cancer
patients rose to 48.6% (incidence of 30.1/100,000), becoming the
most frequently reported cancer in men, while prevalence in female
cancer patients climbed to 17.9% (incidence of 11.0/100,000)
(Wabinga et al., 1993). Since the HIV epidemic, KS has become as
common in women as in men and is prevalent also in many African
countries where it was almost unknown but where HHV-8 has been
shown to be prevalent (Dedicoat and Newton, 2003). These
observations point to a role for other factors in the aetiology of
KS including the possibility that different HHV-8 variants spread
during HIV/AIDS epidemic.
The aim of the present study was to analyze variations of HHV-
8 genomes in tumor biopsies collected before and in the course of HIV
epidemic, from patients with classic, iatrogenic, endemic as well as
epidemic KS living in Africa, Europe and North America. The
identiﬁcation and characterization of HHV-8 variants has been
focused on the highly conserved ORF 26 and T0.7, the hypervariable
ORF K1 as well as on the analysis of P and M alleles of the K14.1/15
locus. Furthermore, sequence alignments and phylogenetic analyses
have been performed to identify variant clusters and to determine the
relationship between the HHV-8 variants identiﬁed in this study with
those described previously.Results
Epidemiological and clinical parameters of patients
This study included a total of 68 cases of cutaneous KS lesions.
Fourteen cases (all in males) were endemic and 9 cases (3 in females
and 6 in males) were epidemic tumor types diagnosed in Black
patients from sub-Saharan African countries during 1971 to 1975 and
during 1990 to 1991, respectively; the median age at the diagnosis
was 49 years (mean±SD=49.5±13.8) for endemic and 27 years
(mean±SD=29.2±8.2) for epidemic KS patients (pb0.001). Thirty-
ﬁve cases (7 in females and 28 in males) were non-epidemic
(including 33 classic and two iatrogenic tumors) and 10 cases (all in
males) were epidemic KS diagnosed in Caucasian patients from
Europe and North America during 1975 to 2008 and during 1990 to
1991, respectively; themedian age was 75 years (mean±SD=70.4±13.5) for classic and 40.5 years (mean±SD=43.0±12.1) for AIDS-
associated KS (pb0.0001).
ORF 26 and T0.7 genetic variability
PCR amplimers obtained from the 68DNA sampleswere sequenced
across the ORF 26 locus (nt 604 to 1602) (Chang et al., 1994)
encompassing the promoter as well as the whole coding region. All
differences between sample sequences are summarized in Table 1.
There were 22 sequence patterns of which 12 can be distinctly
identiﬁed asmolecular HHV-8 subtypes because of their presence in at
least three samples of this study and/or their identiﬁcation in previous
studies. Sequences from African patients mainly belong to the R (12
out of 23, 52.2%), B (5 out of 23, 21.7%) and J (4 out of 23, 17.4%)
subtypes. Only two samples (8.7%) fall into Q subtype. Nine of the 12
samples within the subgroup designated R, coming from Africa, show
an additional novel nucleotide change at position 647 (G to A).
Furthermore, three out of the four B2 African samples and all samples
in the J group show three novel nucleotide changes consisting of T-to-C
transitions at nucleotide positions 663, 683 and 686. Only one
Ugandan sample, UG-111 belongs to B1 group. Furthermore seven
DNA amplimers, which presented novel sporadic nucleotide changes
in the ORF 26 locus, fell into the K subclass (GR-100, G to C at nt 1055;
GR-101, G to C at nt 1294, C to T at nt 1397 and C to A at nt 1735), the R
subclass (UG-85, A to G at nt 1057, C to T at nt 1754; UG-107, C to A at
nt 1177; UG-124, C to T at nt 1158, T to G at nt 1631; UG-915, A to G at
nt 1141) and the subtype J (GR-94, G to T at nt 704 and A to C at nt
1676). Thirty-six out of 45 (80%) ORF 26 sequences obtained from
European and North American patients belong to the A/C class,
following the recent nomenclature by Zong et al. (2007). Only 9 out of
45 (20%) sequences clusteredwithin other classes: one sequence from
anAmerican patient (US-217) belongs to R; one from an Italian patient
(IT-226) belongs to B2; two fromGreece (GR-92 and GR-94), one from
Italy (IT-220) and two from USA (US-133 and US-215) belong to J
class; and two from Greece (Gr-100 and GR-101) belong to K class.
Notably, only 3 out of 7 (42.9%) sequences from Greek patients
clustered into the A/C subtype. Forty-eight samples have been
subjected to sequence analysis of a region extending 307 nucleotides
beyond the stop codon within the ORF 26 locus, as recently
described by Zong et al (2007). All non-A/C and non-J samples
showed several additional nucleotide changes which correlate with
nucleotide signature patterns identiﬁed within the ORF 26 coding
region (Table 1).
Moreover, 22 DNA samples were ampliﬁed and sequenced across
the T0.7 locus (648 bp). Among the 12 sequences from African
patients, the majority belongs to the B1 (6 out of 12, 50%), B2 (4 out of
12, 33.3%) and B3 (1 out of 12, 8.3%) subtypes. Only one (8.3%) falls
into C4 subtype. Nine of the 10 samples (90%) from Caucasian patients
fall within the subgroup designated A/C, and only one (10%) belongs
to the A3 class (Table 2). The GenBank accession numbers of the ORF
26 sequences are GQ252654 to GQ252673 and GU097394 to
GU097415, and those of the ORF T0.7 are GU238289-GU238311.
Variability of ORF K1 and genetic linkage to ORF 26 and T0.7
Forty-two DNA samples were ampliﬁed with primer pairs speciﬁc
for the K1 promoter and coding sequence (1035 bp) and PCR products
were subjected to direct sequencing analysis. The complete K1
sequence was obtained from 39 samples, while a partial sequence
sufﬁcient to perform phylogenetic analysis was obtained from three
samples. All K1 sequences were different from each other, exhibiting
among themselves 0.3–35.3% nucleotide divergence. Phylogenetic
analysis of the K1 gene was performed comparing the newly
identiﬁed 42 K1 sequences with K1 reference sequences of several
HHV-8 subtypes available in GenBank, including several K1 sequences
of Ugandan samples from patients attending the Uganda Cancer
Table 1
Comparison of polymorphic nucleotide patterns that identify several distinctive subgroups of HHV-8 genomes within the ORF 26 gene locus. Dashes indicate identities to the
prototype A1 class sequence (BCBL-R) in the top line.
Absence of genetic variations relative to the reference is marked with dashes, whereas presence of variant nucleotides is indicated by the nucleotide corresponding letter.
A dot indicates sequence not available. δ indicates nucleotide insertion; δ indicates nucleotide deletion. The numbering system conforms to that used by Zong et al. (2007).
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Table 2
Comparison of polymorphic nucleotide patterns that identify distinctive subgroups of HHV-8 genomes within the T0.7 gene.
Absence of genetic variations relative to the reference is marked with dashes, whereas presence of variant nucleotides is indicated by the nucleotide corresponding letter;
δ indicates nucleotide deletion. The numbering system and class designation conforms to that used by Poole et al. (1999), Kakoola et al. (2001) and Zong et al. (2002).
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neighbor-joining tree of all sequences including the already known
reference subtypes (A, B, C, D, E and F), clearly identiﬁed on the basis
of consistent topological associations and bootstrap values above 90%.
Among the African K1 sequences, 11 were identiﬁed as A5 (52.4%),
four were identiﬁed as B3 (19%), three as B1 (14.3%), two as C (9.5%)
and one sequence as subtype F (4.8%). Among the European and North
American K1 sequences, 14 were identiﬁed as A (66.7%) and seven as
C (33.3%) subtypes. Other K1 variants (D, E and Z) were not detected.
The GenBank accession numbers of the 42 new ORF K1 sequences
are FJ884606 to FJ884626 and GU097416 to GU097435.
K14.1/15 P and M genotypes
K14.1/15 genomic region at the right-hand side of HHV-8 genomes
has been ampliﬁed in all 68 samples using a triple primer PCR set,
covering the divergent junction of the two subtypes of K15 gene,
designed to distinguish the P (362 bp) from the M (450 bp) allele on
the basis of the ampliﬁed product size; a further speciﬁc primer set
has been used to amplify K15 M (370 bp) (Poole et al., 1999). All
samples except one had the P allele. The single K14.1/15 M allele was
identiﬁed in a sample obtained from a Cameroonian patient. These
results are in agreement with previous studies showing a predom-
inance of P allele in most African, European and North American
geographical regions and the segregation of M allele mainly in
Western Africa countries. The 362-bp K14.1/15 amplimers, obtained
from 11 samples including four classic and two epidemic KS from
European, three endemic and two epidemic KS from African patients,
as well as the 450-bp M allele amplimer of a single Cameroonians
sample, were subjected to sequence analysis. All P allele sequences,except one, were 100% identical to the reference strain U85269 (P) in
the analyzed sequence. A single Ugandan sequence (UG-65) showed
two synonymous nucleotide changes at nucleotide positions 238 (T to
C) and 246 (G to C) and one non-synonymous nucleotide substitution
at position 273 (T to C). The M allele of CM-95 sample was identical to
the reference sequence U75698 (M).
HHV-8 variant distribution in endemic, classic, iatrogenic and
epidemic KS
Among the African cases 14 samples (11 from Uganda and 3 from
Cameroon) were endemic KS obtained from skin biopsies during
1971–1975 period before the AIDS epidemic (Levy et al., 1986) and 9
(3 from Uganda and 6 from Kenya) were HIV-associated KS obtained
during 1990–1991 period (Table 3). Using prevalently the ORF 26
subtype distribution, there was not a signiﬁcant difference in the
distribution of R, J and Q genotypes between endemic (50%, 7.1% and
7.1% respectively) and epidemic KS (55.5%, 33.3% and 11.1%,
respectively). Subtype B was identiﬁed only in endemic KS (35.8%)
and was not identiﬁed in the few KS epidemic samples obtained from
Uganda, although B2 subtype was present in more than 50% of
samples from Ugandan patients enrolled at the University of Kampala
in 2001 (Kajumbula et al., 2006).
Twenty-eight classic KS from Italy and USA contained, as expected,
A/C subtype, only the samples IT-226 and US-133 contained B2 and J
subtype, respectively. A major divergence was observed among the
seven Greek samples which were 42.8% within A/C, 28.6% within K
and 28.6% within J subtype. A more heterogeneous distribution was
observed among epidemic KS: 7 out of 10 (70%) belonged to A/C, 2 to J
and 1 USA sample belonged to R subtype.
Fig. 1. Phylogenetic tree based on K1 sequences constructed with the TREECON software. Samples designated CM, GR, IT, KE, UG and US are from Cameroon, Greece, Italy, Kenya,
Uganda and Unites States, respectively (present study). Samples designated with a GenBank numbers followed by UG are from Uganda (Kajumbula et al., 2006). AF1133038,
AF130305, U86667, AF133039, AF178823, AF133040, AF130259, AY042940, AF133041, AF133042, AF133043, AF133044, AF220292 and AF178810 have been reported in the
GenBank as reference sequences of A1, A2, A3, A4, A5, B1, B2, B3, C1, C3, D1, D2, E and F subtypes, respectively. Sample designation Cl, En, Ep and Iat indicates classic, endemic,
epidemic and iatrogenic KS, respectively. Corresponding subtypes of the ORF 26 has been also reported near the sequence name: ●, A/C; ■, J; , K; , Q; ▴, R; ⧫, B2; R, B1. Numbers
above the branches indicate the bootstrap values that are grater than 90%.
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Table 3
Clinical and epidemiological features of the patients included in the study and designation of HHV-8 variants of ORF 26, T0.7, K1 and K14.1/K15 amplimers.
Region Year of diagnosis Sample ID Age Sex HIV/Risk factors Country Diagnosis ORF K1 class ORF 26 class T0.7 K14.1/K15
Africa 1971 UG-15 55 M − Uganda Endemic A5 B2 B1 P
1971 UG-18 35 M − Uganda Endemic B3a B2 B2 P
1972 UG-64 70 M − Uganda Endemic C J B1 P
1972 UG-65 67 M − Uganda Endemic B1 R B1 P
1973 UG-80 34 M − Uganda Endemic B3 B2 B2 P
1973 UG-85 35 M − Uganda Endemic B3 R P
1974 CM-90 60 M − Cameroon Endemic A5 R P
1974 CM-95 58 M − Cameroon Endemic A5 R C4 M
1974 UG-107 49 M − Uganda Endemic R B1 P
1974 UG-110 42 M − Uganda Endemic Q B3 P
1974 UG-111 34 M − Uganda Endemic B1 B1 P
1975 UG-120 66 M − Uganda Endemic B3 B2 P
1975 UG-124 39 M − Uganda Endemic A5 R P
1975 CM-116 37 M − Cameroon Endemic A5 R B1 P
1990 UG-206 20 F + Uganda Epidemic A5 R P
1990 UG-208 36 M + Uganda Epidemic A5 R P
1990 UG-915 25 M + Uganda Epidemic A5 R P
1991 KE-229 21 F + Kenya Epidemic A5 Q P
1991 KE-230 34 M + Kenya Epidemic C J B1 P
1991 KE-231 32 M + Kenya Epidemic A5 R P
1991 KE-232 45 M + Kenya Epidemic B1 J B2 P
1991 KE-233 27 F + Kenya Epidemic A5 J B2 P
1991 KE-234 23 M + Kenya Epidemic F R P
Europe 1983 IT-161 54 M − Italy Classic A3 A/C P
1983 IT-164 20 M − Italy Classic A/C P
1984 IT-165 75 M − Italy Classic A/C P
1984 IT-166 65 M − Italy Classic A/C P
1984 IT-169 83 M − Italy Classic A/C P
1984 IT-170 56 M − Italy Classic A1 A/C P
1984 IT-171 63 F − Italy Classic A/C P
1985 IT-172 75 F − Italy Classic A/C P
1985 IT-173 71 F − Italy Classic A/C P
1985 IT-176 68 M − Italy Classic A A/C P
1990 IT-181 32 M + Italy Epidemic A/C P
1990 IT-E40 42 M +/Hemoph Italy Epidemic A4 A/C P
1991 IT-218 65 M − Italy Classic A/C P
1991 IT-219 37 M + Italy Epidemic A/C P
1991 IT-220 39 M + Italy Epidemic C3 J A/C P
1991 IT-221 66 M − Italy Classic A/C P
1991 IT-222 74 M − Italy Classic A/C P
1991 IT-224 74 M − Italy Classic A/C A/C P
1991 IT-225 78 M − Italy Classic A/C P
1991 IT-226 79 M − Italy Classic C B2 P
1991 IT-228 65 M + Italy Epidemic A/C P
1992 GR-03 77 M − Greece Classic A3 A/C P
1992 GR-77 88 M − Greece Classic A3 A/C A/C P
1992 GR-92 81 M − Greece Classic C1 J A/C P
1992 GR-93 47 M Transplanted Greece Iatrog A3 A/C A3 P
1992 GR-94 53 M Transplanted Greece Iatrog A3 J A/C P
1992 GR-100 78 M − Greece Classic C K P
1992 GR-101 65 F − Greece Classic C1 K A/C P
1996 IT-235 80 F − Italy Classic A/C P
2002 IT-268 80 M − Italy Classic A3 A/C P
2002 IT-272 75 F − Italy Classic A/C P
2003 IT-276 76 M − Italy Classic A4 A/C P
2004 IT-281 80 M − Italy Classic A/C P
2008 IT-285 70 F − Italy Classic A/C P
North America 1975 US-114 76 M − USA Classic A4 A/C A/C P
1975 US-123 87 M − USA Classic A/C P
1976 US-133 81 M − USA Classic C1 J A/C P
1977 US-148 49 M − USA Classic A/C P
1977 US-150 79 M − USA Classic A/C P
1990 US-151 76 M − USA Classic A/C P
1990 US-183 52 M + USA Epidemic A/C P
1990 US-187 59 M + USA Epidemic A4 A/C P
1990 US-215 43 M + USA Epidemic C J A/C P
1990 US-216 29 M + USA Epidemic A1 A/C P
1990 US-217 32 M + USA Epidemic A5 R P
a Phylogeny determined on K1 partial sequence.
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allowed the identiﬁcation of 9 genetic patterns all present within the
12 genotype patterns deﬁned by Hayward and Zong (2007). Thus,
viral gene chimerism does not seem to be a currently frequentphenomenon in strain reassortment. Moreover, based on the analysis
of ORF 26, T0.7 and K1 variability, there was no clear molecular
aggregate reﬂecting the period of tumor collection or clinical-
epidemiological type of KS.
Table 4
PCR primer sequences used to amplify HHV-8 genome regions.
Locus Primer name Sequences (5′–3′) Nucleotide position Amplicon size (bp) References
ORF 26233 KS26233A AGCCGAAAGGATTCCACCAT 47,386–47,405 233 bp Chang et al. (1994)
KS26233B TCCGTGTTGTCTACGTCCAG 47,599–47,618
ORF 26 KS26/D GCTAACCCTTCTAGCGTTGGC 47,006–47,026 999 bp This study
KS26/E CTTGCAACCGACAGAATATCAG 47,983–48,004
ORF 26 LGH2575-R GTGCTTGACGATCTGTCC 47,638–47,655 620 bp Zong et al. (2007)
LGH2574-L CAGAAACAGGGCTAGGTAC 48,239–48,257
K1 LGH2089 GTTCTGCCAGGCATAGTC 21–38 1035 bp Poole et al. (1999)
LGH2088 AATAAGTATCCGACCTCAT 1,037–1,055
K1-5′ K1 A TTTGTGGCGGCCCTTGTGTA 43–62 522 bp This study
K1 B ACCCCTCAGTTTGGCTCATCAG 543–564
K1-3′ K1 C GTGTGCACAGCCATCAA 401–417 689 bp This study
K1 D TTTTAATAAGTATCCGACCTCA 1,068–1,089
T0.7/K12-5′ LGH2076 GCTGCAATGTACTGCCATG 117,288–117,306 485 bp Zong et al. (2002)
LGH2017 CATTCAGGACACGAGTTGC 117,754–117,772
T0.7/K12-3′ LGH2018 TGCTTTAATGCGGAGAGG 117,538–117,555 398 bp Zong et al. (2002)
LGH2075 CTCCAATCCCAATGCATGGA 117,916–117,935
K14.1 (P) LGH2079 GAGATCACTCTCCAACCAC 134,548–134,566 363 bp Poole et al. (1999)
LGH2033 GGAGTGCCTTCCGTATAG 134,892–134,909
K14.1 (M) LGH2079 GAGATCACTCTCCAACCAC 134,400–134,418 450 bp Poole et al. (1999)
LGH2506 CACAGTCACCTATGCTAG 134,832–134,849
K15 (M) LGH2473 CATGCAGCGAGCTTGAGA 136,045–134,062 370 bp Poole et al. (1999)
LGH2474 CTTTGAGTACTGTTTGTG 136,397–136,414
Nucleotide positions of HHV-8 ORF 26, K1 and K14.1/15 (P) primers are given on the GenBank sequence number NC_009333 and K14.1/15 (M) on the GenBank sequence number
NC_003409. Nucleotide positions of HHV-8 T0.7 are given on the GenBank sequence number GQ_994935.1.
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Before the onset of the AIDS epidemic in the early 1980 s, KS
showed extreme geographical variation in incidence even within the
African continent, with particularly high rates in Zaire, Uganda and
Tanzania (Cook-Mozaffari et al., 1998). Seroepidemiological studies,
however, conducted on samples collected before AIDS epidemic
showed that several populations in sub-Saharan African have had also
in the past high HHV-8 seroprevalence but endemic KS was conﬁned
primarily to East and Central Africa and variably in West Africa
(Dedicoat and Newton, 2003). Several studies have analyzed the
genetic variation of HHV-8 and have mapped the ethno-geographic
distribution of major clades (Hayward and Zong, 2007), but few
reports are available on HHV-8 variant distribution before the AIDS
epidemic, particularly in geographical regions where major changes
in KS incidence have occurred in association with HIV infection.
In this study, the genetic variations of three different genomic loci
of HHV-8, the conserved ORF 26 and T0.7 and the hypervariable K1
region as well as the P or M alleles of the K14.1/K15 junction segment
have been analyzed in endemic, classic, iatrogenic and epidemic KS in
patients from sub-Saharan Africa, Italy, Greece and USA. The endemic
African KS were diagnosed during 1971–1975, in a period preceding
AIDS epidemic (Levy et al., 1986), and AIDS-associated KS diagnosed
during 1990–1991. Based on the complete sequence of ORF 26 and
according to the classiﬁcation of Zong et al. (2007), subtype B2 was
mainly detected in endemic KS, while R subtype, former C3, followed
by J where similarly represented in both tumor types. The absence of
ORF 26 subtype B2 in our epidemic KS, however, may bemerely due to
the underrepresentation of Ugandan epidemic KS versus the higher
number of Kenyan cases. In a recent study performed on HHV-8-
positive DNA samples isolated from peripheral blood of 31 Ugandan
patients with epidemic KS, indeed the B2 and the R subtype of the ORF
26 predominated across 11 Ugandan ethnic group with no evidence
of distinct ethnic or geographic distribution (Zong et al., 2007;
Kajumbula et al., 2006). Moreover, the ORF 26 J subtype, previously
identiﬁed among two subjects of Ganda tribe (Zong et al., 2007;
Kajumbula et al., 2006), was also found among one endemic Ugandan
KS and three epidemic Kenyan KS samples in the present study. The
majority of African samples, including the four ORF 26 J variants, werefound to belong to ORF T0.7 B1 and B2 subtypes, which have been
shown to predominate in sub-Saharan Africa (Zong et al., 2002).
Phylogenetic studies based on the complete K1 gene indicate that
A5, B3 and B1 variants were present among epidemic KS and, in
agreement with previous results by Kakoola et al. (2001), the A5 and
B3 were predominating. One sample from a Kenyan epidemic KS (KE-
234) clustered with samples K1–43/Berr (France) (Lacoste et al.,
2000), San2 (Botswana) (Whitby et al., 2004) and HKS22 (Uganda)
(Kajumbula et al., 2006) within the new subtype F, contributing to the
designation of this subtype as a new African variant. Comparison of
the subtype assignments at the conserved ORF 26 and hyper variable
K1 region resulted in a strong linkage between the two loci: all K1 B3
and all A5 sequences, except one, were linked to B2 ORF 26 subtype.
All African viral genomes but one had the P allele at the K14.1/15 loci
and, as expected, the single M allele was present in a tumor sample
from a Cameroonian patient. These results are in agreement with
previous studies reporting a high prevalence of P allele in Central-
Eastern Africa and an equal representation of M and P alleles in
Central-Western-African regions (Lacoste et al., 2000;Poole et al.,
1999;Kakoola et al., 2001;Kasolo et al., 2007;Zong et al., 2002). Thus,
HHV-8 subtype distribution in Sub-Saharan Africa, mainly Uganda, is
suggestive of a conserved pattern of HHV-8 variants which has not
changed during AIDS epidemic.
Moreover, HHV-8 variantsORF 26A/C, T0.7A/CandK1Abroadly
predominated in classic and epidemic KS from Italian and USA patients
diagnosed during 1975–2008. Only one classic (US-133) and one
epidemic KS (IT-220) showed ORF 26 J, linked to T0.7 A/C and K1 C
subtype. Moreover, among Greek cases 57% contained ORF 26 A/C and
43% J variants and all but one showed ORF T0.7 A/C subtype. All the
sampleswere positive for P allele at K14.1/15 locus in concordancewith
the lowprevalence ofM alleles among FrenchKS patients (Lacoste et al.,
2000).Higher prevalenceofMalleles has been reported in patients from
Scandinavia (2 out of 5 classic KS cases with K15 M allele virus, 40%),
from Israel (1 out of 4 classic KS with K15M allele virus, 25%) and from
Saudi Arabia (2 out of 7 iatrogenic KS with K15 M allele virus, 28.6%)
(Poole et al., 1999; Zong et al., 2002). Moreover, among Russian KS
patients, a frequency of 57% (4out of 7 cases) and28% (9out of 32 cases)
of K15Mallele viruswas reported by Lacoste et al. (2000) and Kadyrova
et al. (2003), respectively.
287M.L. Tornesello et al. / Virology 398 (2010) 280–289In a previous study including classic and AIDS-associated KS
primarily in patients from Tennessee and Maryland (USA), Zong et al.
(2002) reported the identiﬁcation of a considerable number of M
alleles. This observation could have been due to different ethnic
background of patients, indeed Zhang et al. (2001), who reported a
prevalence of 56% K15 M and 44% K15 P genotypes among patients
with KS in South Texas, presumably linked to the large predominance
of Hispanic population in this region.
Several studies have reported that HHV-8 subtype K1 A display
more aggressive characteristics of pathogenicity in HIV-associated KS
(Boralevi et al., 1998). In a recent studies on classic KS, it has been
reported that subtype A was signiﬁcantly more frequently isolated in
patients affected by classic KSwith high viral load and fast progression
than in individuals with low viral load and slow progression in which
subtype C was prevalent (Mancuso et al., 2008). Conversely HHV-
8 subtype E, identiﬁed among Amerindians tribes with a 53% HHV-
8 seroprevalence, seems to be not associated with KS development
given the very low incidence of the tumor in this population (Biggar et
al., 2000). However, in other studies, the correlations between
genotype and HHV-8-related pathologies with a different degree of
aggressiveness were not conﬁrmed (Cook et al., 1999;Lacoste et al.,
2000). Paradigmatic is the observation that K1 A5 and B subtypes,
prevalent in Uganda, were also hyperendemic in Botswana (Whitby et
al., 2004), a country with high prevalence of HHV-8 infection and low
incidence of KS, suggesting that besides HHV-8 infection, a still
unknown cofactor is necessary for KS development.
HHV-8 infection and KS development have also been linked to a
predisposing genetic background. Some studies have shown that
variability in alleles of the human leukocyte antigen (HLA) complex,
particularly those encoding HLA-DR, may inﬂuence response to
infection with several human pathogens and have been suggested as
markers of susceptibility to KS development (Gaya et al., 2004). This
observation suggests the need for evaluating the risk of progression
associatedwithHHV-8 variants in a larger study population alongwith
determination of HLA haplotypes and HLA-DR polymorphisms.
In conclusion, this study adds new insight to the current
knowledge of worldwide HHV-8 molecular epidemiology by provid-
ing the ﬁrst in depth analysis of the viral genetic variability in African
patients diagnosed with epidemic KS and with endemic KS prior of
AIDS epidemic and in North America and European patients with
classic and with epidemic KS. Although the virus has genetic regions
of high variability, approaching that of HIV-1 env gene, the HHV-
8 subtypes remained stably distributed before and after the AIDS
epidemic. These results suggest that the increased incidence of
epidemic KS in low-incidence countries was not related to the
spreading of high pathogenic HHV-8 variants and furthermore
suggest the presence of other cofactors in high-risk KS countries
pre-existing in the pre-AIDS era.
Materials and methods
Kaposi's sarcoma patients and DNA sample isolation
All tissue specimens were obtained from KS skin lesions and
preserved in liquid nitrogen at −192 °C. African samples were from
the University Centre for Health Sciences, Yaounde, Cameroon (n=3
endemic), from the Pathology Department of Nairobi University in
Kenya (n=6 epidemic) and from the Mulago Hospital and Makerere
University in Kampala, Uganda (n=11 endemic and n=3 epidemic).
European cases were from Pathology Department of Athens Univer-
sity Medical School, Greece (n=5 classic and n=2 iatrogenic), from
the Institutes of Dermatological Sciences, University and IRCCS
Ospedale Maggiore of Milan in North Italy (n=7 classic, and n=3
epidemic) and from the Dermatology Department of Second Univer-
sity of Naples, in South Italy (n=16 classic and n=2 epidemic);
North American cases (n=6 classic and n=5 epidemic) were fromNew York's Sloan-Kettering/Memorial Hospital New York City, USA.
DNA from frozen biopsies was extracted by proteinase K treatment
(150 μg per ml at 60 °C for 30 min) in lysis buffer (10 mM Tris–HCl
pH 7.6, 5 mM EDTA, 150 mM NaCl, 1% SDS), followed by phenol and
phenol–chloroform–isoamyl alcohol (25:24:1) DNA extraction and
ethanol precipitation in 0.3 M sodium acetate (pH 4.6). Genomic
DNA from 61 cases was previously extracted and subjected to PCR
ampliﬁcation with oligonucleotides amplifying a 233-bp DNA
fragment within the HHV-8 ORF 26 (Buonaguro et al., 1996;Chang
et al., 1994). Six previously uncharacterized tumors from patients
undergoing surgical resection from 1996 to 2008 were extracted
and included in this study. DNA quality test was carried out on all
DNA samples by ampliﬁcation with speciﬁc oligoprimers targeting a
fragment within the exon 7 of TP53 gene (Buonaguro et al., 1996),
and DNA quantity analysis, evaluated by spectrophotometric
measurements, provided data that all samples were suitable for
the viral DNA ampliﬁcations.
PCR ampliﬁcation of ORF 26, K1 and K14.1/15 region
Five segments of the HHV-8 genomes were ampliﬁed by PCR: (1)
ORF 26 (999 bp); (2) K1 (1068 bp); (3) ORF T0.7 (648 bp) ; (4) K14.1/
K15 (P) (363 bp) and K14.1/K15 (M) (450 bp), covering the divergent
K14.1/K15 junction of the two alleles; and (5) K15 M allele (370 bp).
Primers and nucleotide positions are listed in Table 4. PCR ampliﬁ-
cation reactions were performed in 50 L reaction mixture containing
100 to 300 ng of target DNA, 20 pmol of each primer, 50 mM KCl,
2.5 mMMgCl2, 100 mM Tris–HCl pH 8.3, 0.1% Triton X-100, 50 mM of
each dNTP and 1.8 U of thermostable AmpliTaq DNA polymerase
(Applied Biosystems, Foster City CA). DNA was ampliﬁed in a Perkin-
Elmer GeneAmp PCR System 9700 thermal cycler with the following
steps: an initial 1-min denaturation at 94 °C, followed by 40 cycles of
55 °C for 1 min, 72 °C for 2 min, 94 °C for 30 s and a ﬁnal annealing at
55 °C for 1 min with 5-min elongation at 72 °C. A reaction mixture
containing genomic DNA, extracted from NIH 3T3 murine cell line,
was used as negative control andwas included in every set of 5 clinical
specimens.
Nucleotide sequencing and phylogenetic analysis
PCR ampliﬁcation products were extracted with phenol and
chloroform-isoamyl alcohol and puriﬁed by precipitation at 37 °C
for 15 min in 1.25 M NaCl with 10% polyethylene glycol (PEG 6000)
(Tornesello et al., 2000). Puriﬁed DNA samples were subjected to
direct nucleotide sequencing (Winship, 1989). Brieﬂy DNA samples
(30–100 ng) were denatured at 95 °C, in presence of 10% DMSO,
immediately cooled in liquid nitrogen and subsequently sequenced
with the Sequenase 2.0 kit according to manufacturer's instructions
(GE Healthcare) modiﬁed in the labeling step (3 min on ice). Aliquots
of PCR ampliﬁed products were further sequenced on both strands by
Primm Srl Laboratorie (Milan, Italy) using the ﬂuorescent dye
terminator technology and ABI 3730 DNA sequencers (Applied
BioSystems, Foster City, CA). Nucleotide sequences were edited with
Chromas Lite 2.01 (http://www.technelysium.com.au/chromas.
html) and converted to FASTA format.
Multiple sequence alignments of HHV-8 sequences from the
present study and reference strains reported in the GenBank were
performed with clustal W tool of MegAlign program of the
Lasergene software (DNASTAR Inc., V7.0.0). Phylogenetic trees
were constructed transforming the aligned sequence data into a
distance matrix by the Kimura's two parameter model (Kimura,
1980), followed by the neighbor-joining bootstrap analysis (Saitou
and Nei, 1987), which was executed with the TREECON software
package (Van de and De, 1994). Boot strapping, with 1000
replicates conﬁrmed the robustness of the three major branches
with bootstrap values above 90%.
288 M.L. Tornesello et al. / Virology 398 (2010) 280–289Statistical analysis
The data were analyzed with Epi Info 6 Statistical Analysis System
Software (Version 6.04b, 1997, Centers for Disease Control and
Prevention, USA). Unpaired t test was used for comparisons of
continuous variables (i.e. age); Yates-corrected χ2 test and, where
appropriate, two-sided Fisher's exact test were used for comparison of
categorical data. Differences were considered to be statistically
signiﬁcant when p values were less than 0.05.
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